nodes	percent_of_prediction	percent_of_DWPC	metapath
Triflupromazine—ABCB1—esophageal cancer	0.67	1	CbGaD
Triflupromazine—BCHE—Cisplatin—esophageal cancer	0.177	0.705	CbGbCtD
Triflupromazine—ABCB1—Cisplatin—esophageal cancer	0.0448	0.179	CbGbCtD
Triflupromazine—ABCB1—Methotrexate—esophageal cancer	0.0291	0.116	CbGbCtD
Triflupromazine—BCHE—diaphragm—esophageal cancer	0.00878	0.446	CbGeAlD
Triflupromazine—HTR2B—smooth muscle tissue—esophageal cancer	0.0011	0.0558	CbGeAlD
Triflupromazine—CHRM1—trachea—esophageal cancer	0.00101	0.0515	CbGeAlD
Triflupromazine—HTR2B—digestive system—esophageal cancer	0.000868	0.0441	CbGeAlD
Triflupromazine—BCHE—bronchus—esophageal cancer	0.000825	0.0419	CbGeAlD
Triflupromazine—BCHE—smooth muscle tissue—esophageal cancer	0.000807	0.041	CbGeAlD
Triflupromazine—BCHE—trachea—esophageal cancer	0.000741	0.0376	CbGeAlD
Triflupromazine—CHRM1—lung—esophageal cancer	0.000729	0.037	CbGeAlD
Triflupromazine—HTR2B—lung—esophageal cancer	0.000725	0.0368	CbGeAlD
Triflupromazine—BCHE—digestive system—esophageal cancer	0.000638	0.0324	CbGeAlD
Triflupromazine—DRD2—lung—esophageal cancer	0.000587	0.0298	CbGeAlD
Triflupromazine—BCHE—lung—esophageal cancer	0.000532	0.027	CbGeAlD
Triflupromazine—HTR2B—lymph node—esophageal cancer	0.000496	0.0252	CbGeAlD
Triflupromazine—ABCB1—epithelium—esophageal cancer	0.000399	0.0203	CbGeAlD
Triflupromazine—BCHE—lymph node—esophageal cancer	0.000364	0.0185	CbGeAlD
Triflupromazine—ABCB1—trachea—esophageal cancer	0.000353	0.0179	CbGeAlD
Triflupromazine—ABCB1—digestive system—esophageal cancer	0.000304	0.0154	CbGeAlD
Triflupromazine—ABCB1—lung—esophageal cancer	0.000254	0.0129	CbGeAlD
Triflupromazine—Desipramine—CYP2A6—esophageal cancer	0.000185	0.201	CrCbGaD
Triflupromazine—ABCB1—lymph node—esophageal cancer	0.000174	0.00881	CbGeAlD
Triflupromazine—Diltiazem—ABCB1—esophageal cancer	0.000136	0.148	CrCbGaD
Triflupromazine—Fluphenazine—ABCB1—esophageal cancer	9.34e-05	0.101	CrCbGaD
Triflupromazine—Clomipramine—ABCB1—esophageal cancer	8.54e-05	0.0928	CrCbGaD
Triflupromazine—Chlorprothixene—ABCB1—esophageal cancer	8.5e-05	0.0924	CrCbGaD
Triflupromazine—Promethazine—ABCB1—esophageal cancer	7.57e-05	0.0822	CrCbGaD
Triflupromazine—Trifluoperazine—ABCB1—esophageal cancer	7.46e-05	0.0811	CrCbGaD
Triflupromazine—Desipramine—ABCB1—esophageal cancer	6.87e-05	0.0747	CrCbGaD
Triflupromazine—Chlorpromazine—ABCB1—esophageal cancer	5.86e-05	0.0637	CrCbGaD
Triflupromazine—Imipramine—ABCB1—esophageal cancer	5.83e-05	0.0633	CrCbGaD
Triflupromazine—CHRM2—Signaling by GPCR—CXCL2—esophageal cancer	4.46e-05	0.000757	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—SST—esophageal cancer	4.44e-05	0.000754	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—ALDH2—esophageal cancer	4.4e-05	0.000747	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—GHRL—esophageal cancer	4.39e-05	0.000745	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—HIST1H2BM—esophageal cancer	4.35e-05	0.000739	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—GNG7—esophageal cancer	4.35e-05	0.000738	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CSNK1A1—esophageal cancer	4.33e-05	0.000736	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—GHRL—esophageal cancer	4.33e-05	0.000735	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PDE4D—esophageal cancer	4.31e-05	0.000732	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—ANXA1—esophageal cancer	4.29e-05	0.000729	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CSNK1A1—esophageal cancer	4.24e-05	0.00072	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—ANXA1—esophageal cancer	4.2e-05	0.000713	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—GSTT1—esophageal cancer	4.19e-05	0.000711	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CSNK1A1—esophageal cancer	4.19e-05	0.000711	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—SST—esophageal cancer	4.18e-05	0.000709	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	4.15e-05	0.000705	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—ANXA1—esophageal cancer	4.15e-05	0.000704	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—CYP2A6—esophageal cancer	4.14e-05	0.000703	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.12e-05	0.0007	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—GNG7—esophageal cancer	4.1e-05	0.000696	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—SLC10A2—esophageal cancer	4.09e-05	0.000694	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CA1—esophageal cancer	4.09e-05	0.000694	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—SST—esophageal cancer	4.09e-05	0.000694	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—XIAP—esophageal cancer	4.08e-05	0.000692	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—GHRL—esophageal cancer	4.07e-05	0.000691	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PFN1—esophageal cancer	4.05e-05	0.000688	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—SST—esophageal cancer	4.03e-05	0.000685	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	4.03e-05	0.000685	CbGpPWpGaD
Triflupromazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	4.02e-05	0.000683	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—GHRL—esophageal cancer	3.98e-05	0.000676	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PFN1—esophageal cancer	3.97e-05	0.000674	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	3.95e-05	0.00067	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—GHRL—esophageal cancer	3.93e-05	0.000668	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—ENO1—esophageal cancer	3.92e-05	0.000666	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PTGS1—esophageal cancer	3.92e-05	0.000666	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PFN1—esophageal cancer	3.92e-05	0.000665	CbGpPWpGaD
Triflupromazine—CHRM1—G alpha (q) signalling events—PIK3CA—esophageal cancer	3.9e-05	0.000663	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PSME1—esophageal cancer	3.87e-05	0.000656	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PSME2—esophageal cancer	3.87e-05	0.000656	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CTNNA1—esophageal cancer	3.85e-05	0.000654	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—XIAP—esophageal cancer	3.84e-05	0.000652	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CXCL2—esophageal cancer	3.83e-05	0.00065	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CA2—esophageal cancer	3.74e-05	0.000635	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ELMO1—esophageal cancer	3.64e-05	0.000618	CbGpPWpGaD
Triflupromazine—DRD2—Circadian rythm related genes—TP53—esophageal cancer	3.64e-05	0.000618	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CTNNA1—esophageal cancer	3.63e-05	0.000617	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CXCL2—esophageal cancer	3.61e-05	0.000613	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PSME1—esophageal cancer	3.58e-05	0.000608	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PSME2—esophageal cancer	3.58e-05	0.000608	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	3.56e-05	0.000605	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ELMO1—esophageal cancer	3.56e-05	0.000605	CbGpPWpGaD
Triflupromazine—CHRM1—Circadian rythm related genes—TP53—esophageal cancer	3.56e-05	0.000605	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—ANXA1—esophageal cancer	3.56e-05	0.000605	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AKAP13—esophageal cancer	3.56e-05	0.000604	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ELMO1—esophageal cancer	3.52e-05	0.000597	CbGpPWpGaD
Triflupromazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	3.49e-05	0.000593	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AKAP13—esophageal cancer	3.48e-05	0.000591	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PLCE1—esophageal cancer	3.48e-05	0.00059	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ADH7—esophageal cancer	3.48e-05	0.00059	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—SST—esophageal cancer	3.46e-05	0.000588	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	3.45e-05	0.000585	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AKAP13—esophageal cancer	3.44e-05	0.000584	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—NOTCH3—esophageal cancer	3.38e-05	0.000573	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—GHRL—esophageal cancer	3.38e-05	0.000573	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.38e-05	0.000573	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PSME1—esophageal cancer	3.38e-05	0.000573	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PSME2—esophageal cancer	3.38e-05	0.000573	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—ANXA1—esophageal cancer	3.36e-05	0.00057	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—CYP1B1—esophageal cancer	3.34e-05	0.000566	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—FBXW7—esophageal cancer	3.32e-05	0.000564	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—HIST1H2BM—esophageal cancer	3.28e-05	0.000558	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	3.28e-05	0.000557	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—SST—esophageal cancer	3.27e-05	0.000555	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PDE4D—esophageal cancer	3.26e-05	0.000553	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—HIST1H2BM—esophageal cancer	3.21e-05	0.000546	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PDE4D—esophageal cancer	3.19e-05	0.000541	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NOTCH3—esophageal cancer	3.18e-05	0.000541	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—GHRL—esophageal cancer	3.18e-05	0.000541	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—HIST1H2BM—esophageal cancer	3.17e-05	0.000539	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PDE4D—esophageal cancer	3.14e-05	0.000534	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—CYP19A1—esophageal cancer	3.14e-05	0.000533	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—FBXW7—esophageal cancer	3.13e-05	0.000532	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—GNG7—esophageal cancer	3.1e-05	0.000526	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ADH1B—esophageal cancer	3.05e-05	0.000518	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—GNG7—esophageal cancer	3.03e-05	0.000514	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—NOTCH2—esophageal cancer	3.03e-05	0.000514	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—GNG7—esophageal cancer	2.99e-05	0.000508	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.98e-05	0.000506	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—TYMP—esophageal cancer	2.91e-05	0.000495	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—XIAP—esophageal cancer	2.9e-05	0.000493	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—HMOX1—esophageal cancer	2.86e-05	0.000486	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	2.86e-05	0.000485	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NOTCH2—esophageal cancer	2.86e-05	0.000485	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—XIAP—esophageal cancer	2.84e-05	0.000482	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYP26A1—esophageal cancer	2.83e-05	0.000481	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.81e-05	0.000477	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—XIAP—esophageal cancer	2.8e-05	0.000476	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	2.8e-05	0.000475	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ALOX15—esophageal cancer	2.76e-05	0.000469	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—ABCB1—esophageal cancer	2.75e-05	0.000466	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CTNNA1—esophageal cancer	2.74e-05	0.000466	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CXCL2—esophageal cancer	2.73e-05	0.000463	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TGFBR2—esophageal cancer	2.69e-05	0.000456	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CTNNA1—esophageal cancer	2.69e-05	0.000456	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CXCL2—esophageal cancer	2.67e-05	0.000453	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CTNNA1—esophageal cancer	2.65e-05	0.00045	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CXCL2—esophageal cancer	2.64e-05	0.000447	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GSTO1—esophageal cancer	2.63e-05	0.000447	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—TPI1—esophageal cancer	2.63e-05	0.000447	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PSME2—esophageal cancer	2.55e-05	0.000433	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PSME1—esophageal cancer	2.55e-05	0.000433	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—SMAD4—esophageal cancer	2.54e-05	0.000432	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ANXA1—esophageal cancer	2.54e-05	0.000431	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TGFBR2—esophageal cancer	2.53e-05	0.00043	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ALDOB—esophageal cancer	2.53e-05	0.000429	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PSME2—esophageal cancer	2.49e-05	0.000423	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PSME1—esophageal cancer	2.49e-05	0.000423	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ANXA1—esophageal cancer	2.48e-05	0.000421	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SST—esophageal cancer	2.47e-05	0.000419	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PSME1—esophageal cancer	2.46e-05	0.000418	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PSME2—esophageal cancer	2.46e-05	0.000418	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ANXA1—esophageal cancer	2.45e-05	0.000416	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GAPDH—esophageal cancer	2.43e-05	0.000413	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	2.43e-05	0.000412	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SST—esophageal cancer	2.41e-05	0.00041	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CRABP1—esophageal cancer	2.41e-05	0.000409	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NOTCH3—esophageal cancer	2.4e-05	0.000408	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—GHRL—esophageal cancer	2.4e-05	0.000408	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—SMAD4—esophageal cancer	2.4e-05	0.000407	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SST—esophageal cancer	2.38e-05	0.000405	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—FBXW7—esophageal cancer	2.37e-05	0.000402	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NOTCH3—esophageal cancer	2.35e-05	0.000399	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—GHRL—esophageal cancer	2.35e-05	0.000399	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.35e-05	0.000399	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NOTCH3—esophageal cancer	2.32e-05	0.000394	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—GHRL—esophageal cancer	2.32e-05	0.000394	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—FBXW7—esophageal cancer	2.31e-05	0.000393	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GNG7—esophageal cancer	2.29e-05	0.000389	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—FBXW7—esophageal cancer	2.29e-05	0.000388	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NOTCH2—esophageal cancer	2.16e-05	0.000366	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ALDH2—esophageal cancer	2.15e-05	0.000365	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NOTCH2—esophageal cancer	2.11e-05	0.000358	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NOTCH2—esophageal cancer	2.08e-05	0.000354	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—HIF1A—esophageal cancer	2.08e-05	0.000353	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.08e-05	0.000353	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GSTT1—esophageal cancer	2.04e-05	0.000347	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYP2A6—esophageal cancer	2.02e-05	0.000343	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—KDR—esophageal cancer	1.99e-05	0.000338	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—HIF1A—esophageal cancer	1.96e-05	0.000333	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PTGS1—esophageal cancer	1.91e-05	0.000325	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ENO1—esophageal cancer	1.91e-05	0.000325	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TGFBR2—esophageal cancer	1.91e-05	0.000325	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.91e-05	0.000325	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PSME2—esophageal cancer	1.89e-05	0.00032	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PSME1—esophageal cancer	1.89e-05	0.00032	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—KDR—esophageal cancer	1.88e-05	0.000319	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—NOTCH1—esophageal cancer	1.87e-05	0.000318	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TGFBR2—esophageal cancer	1.87e-05	0.000318	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TGFBR2—esophageal cancer	1.85e-05	0.000314	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—CREBBP—esophageal cancer	1.84e-05	0.000312	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SMAD4—esophageal cancer	1.81e-05	0.000307	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SMAD4—esophageal cancer	1.77e-05	0.000301	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NOTCH1—esophageal cancer	1.77e-05	0.0003	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SMAD4—esophageal cancer	1.75e-05	0.000297	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CREBBP—esophageal cancer	1.7e-05	0.000289	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—EGFR—esophageal cancer	1.67e-05	0.000284	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—NOS3—esophageal cancer	1.64e-05	0.000279	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYP1B1—esophageal cancer	1.63e-05	0.000276	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CREBBP—esophageal cancer	1.6e-05	0.000272	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—PIK3CA—esophageal cancer	1.6e-05	0.000271	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—EGFR—esophageal cancer	1.58e-05	0.000267	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.53e-05	0.00026	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—NOS3—esophageal cancer	1.52e-05	0.000258	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—PIK3CA—esophageal cancer	1.51e-05	0.000256	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PTGS2—esophageal cancer	1.5e-05	0.000255	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—HIF1A—esophageal cancer	1.48e-05	0.000252	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—HIF1A—esophageal cancer	1.45e-05	0.000246	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—PIK3CA—esophageal cancer	1.45e-05	0.000246	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NOS3—esophageal cancer	1.44e-05	0.000244	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—HIF1A—esophageal cancer	1.43e-05	0.000243	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—ERBB2—esophageal cancer	1.42e-05	0.000242	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—KDR—esophageal cancer	1.42e-05	0.000241	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—HMOX1—esophageal cancer	1.4e-05	0.000237	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—KDR—esophageal cancer	1.39e-05	0.000235	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—KDR—esophageal cancer	1.37e-05	0.000232	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—PIK3CA—esophageal cancer	1.37e-05	0.000232	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—ERBB2—esophageal cancer	1.34e-05	0.000228	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NOTCH1—esophageal cancer	1.33e-05	0.000227	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NOTCH1—esophageal cancer	1.31e-05	0.000222	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NOTCH1—esophageal cancer	1.29e-05	0.000219	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CCND1—esophageal cancer	1.26e-05	0.000214	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—EP300—esophageal cancer	1.25e-05	0.000212	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CDKN1A—esophageal cancer	1.22e-05	0.000207	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CREBBP—esophageal cancer	1.21e-05	0.000205	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—EGFR—esophageal cancer	1.19e-05	0.000202	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CCND1—esophageal cancer	1.19e-05	0.000201	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CREBBP—esophageal cancer	1.18e-05	0.000201	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CREBBP—esophageal cancer	1.17e-05	0.000199	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—EGFR—esophageal cancer	1.16e-05	0.000198	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—EP300—esophageal cancer	1.16e-05	0.000197	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—EGFR—esophageal cancer	1.15e-05	0.000195	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CDKN1A—esophageal cancer	1.15e-05	0.000195	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—PIK3CA—esophageal cancer	1.14e-05	0.000193	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—PIK3CA—esophageal cancer	1.11e-05	0.000189	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—PIK3CA—esophageal cancer	1.1e-05	0.000186	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—EP300—esophageal cancer	1.09e-05	0.000185	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NOS3—esophageal cancer	1.08e-05	0.000184	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NOS3—esophageal cancer	1.06e-05	0.00018	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NOS3—esophageal cancer	1.05e-05	0.000178	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—PIK3CA—esophageal cancer	1.03e-05	0.000175	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ERBB2—esophageal cancer	1.01e-05	0.000172	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—PIK3CA—esophageal cancer	1.01e-05	0.000171	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MYC—esophageal cancer	1.01e-05	0.000171	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—PIK3CA—esophageal cancer	9.97e-06	0.000169	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ERBB2—esophageal cancer	9.92e-06	0.000168	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—EGFR—esophageal cancer	9.87e-06	0.000168	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ERBB2—esophageal cancer	9.79e-06	0.000166	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MYC—esophageal cancer	9.51e-06	0.000162	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—EGFR—esophageal cancer	9.3e-06	0.000158	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PIK3CA—esophageal cancer	9.25e-06	0.000157	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CREBBP—esophageal cancer	8.96e-06	0.000152	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCND1—esophageal cancer	8.95e-06	0.000152	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCND1—esophageal cancer	8.76e-06	0.000149	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CDKN1A—esophageal cancer	8.66e-06	0.000147	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCND1—esophageal cancer	8.65e-06	0.000147	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PIK3CA—esophageal cancer	8.56e-06	0.000145	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CDKN1A—esophageal cancer	8.48e-06	0.000144	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CDKN1A—esophageal cancer	8.37e-06	0.000142	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TP53—esophageal cancer	8.28e-06	0.000141	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—EP300—esophageal cancer	8.24e-06	0.00014	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PIK3CA—esophageal cancer	8.08e-06	0.000137	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—EP300—esophageal cancer	8.07e-06	0.000137	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—NOS3—esophageal cancer	8.02e-06	0.000136	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—EP300—esophageal cancer	7.96e-06	0.000135	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TP53—esophageal cancer	7.81e-06	0.000133	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PTGS2—esophageal cancer	7.34e-06	0.000125	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MYC—esophageal cancer	7.18e-06	0.000122	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MYC—esophageal cancer	7.03e-06	0.000119	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—EGFR—esophageal cancer	7.03e-06	0.000119	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MYC—esophageal cancer	6.94e-06	0.000118	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—EGFR—esophageal cancer	6.88e-06	0.000117	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—EGFR—esophageal cancer	6.79e-06	0.000115	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—EP300—esophageal cancer	6.1e-06	0.000104	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3CA—esophageal cancer	6.1e-06	0.000104	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3CA—esophageal cancer	5.97e-06	0.000101	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TP53—esophageal cancer	5.9e-06	0.0001	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3CA—esophageal cancer	5.89e-06	0.0001	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TP53—esophageal cancer	5.77e-06	9.8e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TP53—esophageal cancer	5.7e-06	9.67e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3CA—esophageal cancer	4.51e-06	7.66e-05	CbGpPWpGaD
